Recently merged landlord also recorded increase in surplus and turnover

Bromford Flagship LiveWest (BFL) saw its completions of affordable homes drop in the first half of the year.

shutterstock_2817674069

Source: Shutterstock

According to a trading update for the six months to 30 September 2026, the 127,000-home provider built 992 affordable tenure homes, out of a total 1,039 homes delivered during the period.

The figure for affordable tenure homes was down on the 1,049 built in the equivalent period the year prior.

The provider was established in January (during the second half of FY25/26) as a result of the merger of Bromford Flagship and LiveWest.

As such, the comparative figures provided in the trading update represent a proportionate share of the combined organisation’s full-year figures, as disclosed in the 2025/26 audited accounts.

Of the 992 affordable homes it built, 429 were for social rent, 271 were affordable rent homes and 292 shared ownership.

“Handovers in the first half of the year were slightly behind target due to planning delays on our land-led developments and slower delivery by some development partners,” it said, adding that it expected handovers to increase in the second half and that it remained on track for its 3,116 full-year target.

BFL said it had seen market conditions “in some geographies suppressing outright sales and shared ownership margins” and that while “these pressures are expected to persist”, its “overall exposure to housing market risk remains low”.

The provider was recently allocated £350m from Homes England’s Social and Affordable Housing Programme, a grant which it said “provides valuable near-term certainty for the delivery of over 2,600 grant-funded homes”, while stressing that it has “the ambition and, we believe, the responsibility to do more, with capacity to deliver over 50,000 homes by 2040”. 

BFL’s active development pipeline currently comprises more than 10,500 homes, over 65% of which are land-led.

The trading update also reported turnover of £419m, up from £396m in the equivalent period the year prior.

The group also recorded a surplus of £96m, up from £94m, while EBITDA MRI interest cover stood at 157%, up from 156%.